US study suggests BMS’ cancer drug could target Parkinson’s-causing protein
The progressive neurodegenerative condition affects more than ten million people worldwide
Read More
Tag: nivolumab/relatlimab
- MRM Health collaborates with Oncode Institute and Netherlands Cancer Institute
- Sobi to acquire Arthrosi Therapeutics, strengthening gout treatment pipeline
- Lindus Health and Quotient Sciences announce strategic partnership to accelerate drug development
- Title21 Health Solutions joins the Blood and Cells Advocacy Roster
- NADMED launches $30,000 metabolomics research award
